Investment Banking
Financial Advisor to the Horizon Technology Finance Corp. Special Committee on Horizon’s Merger with Monroe Capital Corp.
April 20, 2026
Oppenheimer & Co. Inc. Acted as Financial Advisor to the Horizon Technology Finance Corp. Special Committee on Horizon’s Merger with Monroe Capital Corp
On April 14th, 2026, Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon” or the “Company”) announced the closing of the previously announced merger of Monroe Capital Corporation (Previously NASDAQ: MRCC) with and into Horizon, with Horizon remaining as the surviving company.
The combined company will have approximately $471.7 million of net assets on a pro forma basis immediately following closing, including approximately $141.1 million in cash received in connection with the merger. The Company intends to use such cash to repay a portion of its outstanding indebtedness and to make investments in accordance with its investment objective and strategies.
In connection with the closing of the merger, Horizon issued 20,370,693 shares of Horizon common stock in the aggregate, or 0.9402 shares of Horizon common stock for each share of MRCC common stock, to MRCC stockholders (and payment of cash in lieu of fractional shares). Former MRCC stockholders and legacy Horizon stockholders own 29.86% and 70.14% of the combined company, respectively, immediately following the closing of the merger.
Horizon is a leading specialty finance company that provides secured loans to venture capital-backed companies in the technology, life-science, healthcare information & services, and sustainability industries. Horizon is externally managed by Horizon Technology Finance Management LLC, an affiliate of Monroe Capital LLC.
Read the full press release here: Horizon Technology Finance Corporation Closes Merger with Monroe Capital Corporation
Name:
Cliff Booth
Title:Managing Director, Head of Specialty Finance
Name:
JD Nelson
Title:Managing Director
Name:
Adam Markiewicz
Title:Executive Director
Name:
Ethan MacKenzie
Title:Associate
Name:
Alec Azar
Title:Associate
Name:
Teresa Markiewicz
Title:Analyst
DISCLOSURES
This notice is provided for informational purposes only, and is not intended as a recommendation or an offer or solicitation for the purchase or sale of any security or financial instrument. Nothing contained herein shall constitute an offer or solicitation to buy or sell any securities discussed herein in any jurisdiction where such offer or solicitation would be prohibited.
This notice may contain statistical data cited from third-party sources believed to be reliable, but Oppenheimer & Co. Inc. does not represent that any such third-party statistical information is accurate or complete, and it should not be relied upon as such. All market prices, data and other information are not warranted as to completeness or accuracy and are subject to change without notice.
2026 Oppenheimer & Co. Inc. Transacts Business on all Principal US Exchanges and is a Member of SIPC 8878728.1